Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

Mateos, María-Victoria, Hernández, Miguel-Teodoro, Giraldo, Pilar, de la Rubia, Javier, de Arriba, Felipe, Corral, Lucía López, Rosiñol, Laura, Paiva, Bruno, Palomera, Luis, Bargay, Joan, Oriol, Albert, Prosper, Felipe, López, Javier, Olavarría, Eduardo, Quintana, Nuria, García, José-Luis, Bladé, Joan, Lahuerta, Juan-José, San Miguel, Jesús-F.·2013·New England Journal of Medicine
DOI 10.1056/nejmoa1300439

Cited by (1,000)

Items 101–200 of 1,000

  1. Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
    Matteo Bellone, Arianna Brevi, Samuel Huber · 2020 · Microbiology and Molecular Biology Reviews
  2. Multiple Myeloma in the Time of COVID-19
    Abdullah S. Al Saleh, Taimur Sher, Morie Abraham Gertz · 2020 · Acta Haematologica
  3. Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
    Rashid Z Khan, Madhav V. Dhodapkar, Adam Rosenthal, Christoph Johann Heuck, Xenofon Dimitrios Papanikolaou, Pingping Qu, Frits van Rhee, Mauricio Zangari, Yogesh S. Jethava, Joshua Epstein et al. · 2015 · Haematologica
  4. Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients
    Alissa Visram, Camilia M. Soof, S. Vincent Rajkumar, Shaji Kunnathu Kumar, Sean Elliott Bujarski, Tanya Magazinnik Spektor, Robert A. Kyle, James R. Berenson, Angela A. Dispenzieri · 2021 · Blood Cancer Journal
  5. Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma
    Termini, Rosalinda, Žihala, David, Terpos, Evangelos, Perez-Montaña, Albert, Jelínek, Tomáš, Raab, Marc, Weinhold, Niels, Mai, Elias K., Grab, Anna Luise, Corre, Jill et al. · 2022 · Clinical Cancer Research
  6. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases
    Kari Hemminki, Asta Försti, Richard S. Houlston, Amit Sud · 2021 · International Journal of Cancer
  7. How I treat smoldering multiple myeloma
    Irene M. Ghobrial, Ola Landgren · 2014 · Blood
  8. Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma
    Francesco Maura, Niccolò Bolli, Even Holth Rustad, Malin L. Hultcrantz, Nikhil C. Munshi, Ola Landgren · 2019 · JAMA Oncology
  9. Serum protein N-glycosylation changes in multiple myeloma
    Zejian Zhang, Marita Westhrin, Albert Bondt, Manfred Wuhrer, Therese Standal, Stephanie Holst · 2019 · Biochimica et Biophysica Acta (BBA) - General Subjects
  10. A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
    Stina Wichert, Gunnar Juliusson, Åsa C. M. Johansson, Elisabeth Sonesson, Ingrid Teige, Anna Teige Wickenberg, Björn Frendéus, Magnus Korsgren, Markus Hansson · 2017 · PLoS ONE
  11. Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial
    Kazandjian, Dickran, Hill, Elizabeth, Dew, Alexander, Morrison, Candis, Roswarski, Joseph, Korde, Neha, Emanuel, Michael, Petrosyan, Ani, Bhutani, Manisha, Calvo, Katherine R. et al. · 2021 · JAMA Oncology
  12. 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
    Pellegrino Musto, Monika Martha Engelhardt, Jo Caers, Niccolò Bolli, Martin Kaiser, Niels W.C.J. van de Donk, Evangelos Terpos, Annemiek Broijl, Carlos Fernández de Larrea, Francesca Gay et al. · 2021 · Haematologica
  13. Insights on Multiple Myeloma Treatment Strategies
    María‐Victoria Mateos, Heinz Ludwig, Ali A. Bazarbachi, Meral Beksaç, Joan Bladé, Mario Boccadoro, Michèle Cavo, Michel Delforge, Meletios Athanasios Dimopoulos, Thierry T.F. Facon et al. · 2018 · HemaSphere
  14. Plasma Cell Disorders
    Jorge Julio Castillo · 2016 · Primary Care Clinics in Office Practice
  15. The Effect of Kinesio Taping on Muscle Pain, Sprint Performance, and Flexibility in Recovery From Squat Exercise in Young Adult Women
    Tarık Özmen, Mert Aydoğmuş, Hanife Doğan, Derya Acar, TUBA ZOROĞLU, Mark E. T. Willems · 2015 · Journal of Sport Rehabilitation
  16. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice
    Jonathan R. Genzen, David L. Murray, György Ábel, Qing H. Meng, Richard J. Baltaro, Daniel D. Rhoads, Julio C. Delgado, Rhona J. Souers, Christine P. Bashleben, David F. Keren et al. · 2017 · Archives of Pathology & Laboratory Medicine
  17. Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma
    Francesca Bonello, Roberto Mina, Mario Boccadoro, Francesca Gay · 2019 · Cancers
  18. The skinny on obesity and plasma cell myeloma: a review of the literature
    Kenneth Robert Carson, Melissa Lowe Bates, Michael H. Tomasson · 2014 · Bone Marrow Transplantation
  19. Game of Bones: How Myeloma Manipulates Its Microenvironment
    Tyler Moser-Katz, Nisha S. Joseph, Madhav V. Dhodapkar, Kelvin P. Lee, Lawrence Boise · 2021 · Frontiers in Oncology
  20. Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
    Sham Mailankody, Dickran Gano Kazandjian, Neha Korde, Mark J. Roschewski, Elisabet Esteve Manasanch, Manisha Bhutani, Nishant Tageja, Mary Kwok, Yong Zhang, Adriana Zingone et al. · 2017 · Blood Advances
  21. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy
    Jithendra Kini Bailur, Sameet S. Mehta, Lin Zhang, Natalia Neparidze, Terri L. Parker, Noffar Bar, Tara B. Anderson, Mina L. Xu, Kavita M. Dhodapkar, Madhav V. Dhodapkar · 2017 · Blood Advances
  22. The misguided ethics of crossover trials
    Vinay K. Prasad, Christine Grady · 2013 · Contemporary Clinical Trials
  23. Advantages and drawbacks of dexamethasone in glioblastoma multiforme
    Amir R. Afshari, Mehdi Sanati, Samaneh Aminyavari, Farzaneh Shakeri, Bahram Bibak, Zakieh Keshavarzi, Mohammad Soukhtanloo, Mohammad Jalili‐Nik, Mohammad Montazami Sadeghi, Hamid Mollazadeh et al. · 2022 · Critical Reviews in Oncology/Hematology
  24. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model
    Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici, Andrew Paul Cox · 2016 · Pharmacoepidemiology and Drug Safety
  25. Monoclonal Gammopathy of Undetermined Significance
    Wilson I. Gonsalves, S. Vincent Rajkumar · 2022 · Annals of Internal Medicine
  26. Classifying ultra-high risk smoldering myeloma
    Adam Justin Waxman, Rosemarie Mick, Alfred L. Garfall, Adam D. Cohen, Dan T. Vogl, Edward Allen Stadtmauer, Brendan M. Weiss · 2014 · Leukemia
  27. [Oral cancer -diagnosis and therapy-.]
    Takahiko Shibahara · 2017 · PubMed
  28. Renal osteodystrophy and secondary hyperparathyroidism
    Masafumi Fukagawa, Junichiro James Kazama, K. Kurokawa · 2002 · Nephrology Dialysis Transplantation
  29. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessment of Antiangiogenic Treatment Effects in Multiple Myeloma
    Maximilian Merz, Judith Ritsch, Christina Kunz, Barbara Wagner, Sandra Sauer, Dirk Hose, Thomas M. Moehler, Stefan Delorme, Hartmut Goldschmidt, Christian M. Zechmann et al. · 2014 · Clinical Cancer Research
  30. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions
    Maria Stella Graziani, Giampaolo Merlini · 2013 · Expert Review of Molecular Diagnostics
  31. Multiples Myelom – aktuelle Standards in Diagnostik und Therapie
    Michael Kehrer, Sebastian Koob, Andreas Christian Strauss, Dieter Christian Wirtz, Jan Schmolders · 2017 · Zeitschrift für Orthopädie und Unfallchirurgie
  32. Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma
    Erik Lawrence Lum, Edmund Huang, Suphamai Bunnapradist, Thu N. Pham, Gabriel M. Danovitch · 2017 · American Journal of Kidney Diseases
  33. Laboratory assessment of multiple myeloma
    Tracy Morrison, Ronald A. Booth, Kristin D. Hauff, Philip Berardi, Alissa Visram · 2019 · Advances in clinical chemistry
  34. Caregiver Burden, Quality of Life and Vulnerability Towards Psychopathology in Caregivers of Patients with Dementia/Alzheimer's Disease.
    Saima Dawood · 2016 · PubMed
  35. Hard-Wired Bias
    Vinay K. Prasad, Vance W. Berger · 2015 · Mayo Clinic Proceedings
  36. Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study
    Sundar Jagannath, Jacob P. Laubach, Ellice Yuen-Ming Wong, Keith E Stockerl-Goldstein, Cara Ann Rosenbaum, Madhav V. Dhodapkar, Ying‐Ming Jou, Mark John Lynch, Michael D. H. Robbins, Suresh G. Shelat et al. · 2018 · British Journal of Haematology
  37. Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
    Leona Yamamoto, Nicola Amodio, Annamaria Gullà, Kenneth Carl Anderson · 2021 · Frontiers in Oncology
  38. The immune system in multiple myeloma and precursor states: Lessons and implications for immunotherapy and interception
    Madhav V. Dhodapkar · 2022 · American Journal of Hematology
  39. Curative strategy for high-risk smoldering myeloma: carfilzomib, lenalidomide, and dexamethasone (KRd) followed by transplant, KRd consolidation, and Rd maintenance
    Mateos, María-Victoria, Martínez-López, Joaquin, Rodriguez Otero, Paula, González-Calle, Verónica, Gonzalez, Marta Sonia, Oriol, Albert, Gutiérrez, Norma C., Ríos-Tamayo, Rafael, Rosiñol, Laura, Alvarez Rivas, Miguel Angel et al. · 2024 · Journal of Clinical Oncology
  40. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
    Cirino Botta, Cristina Pérez, Marta Larráyoz, Noemí Puig, María‐Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodríguez, Aintzane Zabaleta, Aitziber López et al. · 2023 · Nature Communications
  41. Identification of Friend or Foe: The Laboratory Challenge of Differentiating M-Proteins from Monoclonal Antibody Therapies
    John R. Mills, David L. Murray · 2017 · The Journal of Applied Laboratory Medicine
  42. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis
    Neta Goldschmidt, L. Zamir, Alina Poperno, Natan R. Kahan, Ora Paltiel · 2016 · The Journal of the American Board of Family Medicine
  43. Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma
    Arianna Calcinotto, Maurilio Ponzoni, Roberto Ria, Matteo Grioni, Elena F. Cattaneo, Isabella Villa, Maria Teresa Sabrina Bertilaccio, Marta Chesi, Alessandro Rubinacci, Giovanni Tonon et al. · 2015 · OncoImmunology
  44. ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
    Paola E. Neri, Benjamin G. Barwick, David Jung, Jonathan C. Patton, Ranjan Maity, Inès Tagoug, Caleb K. Stein, Rémi Tilmont, Noémie Leblay, Sungwoo Ahn et al. · 2023 · Blood Cancer Discovery
  45. Shall we treat smoldering multiple myeloma in the near future?
    Ola Landgren · 2017 · Hematology
  46. Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics
    Robert M. Rifkin, Rafat Abonour, Howard R. Terebelo, Jatin J. Shah, Cristina Gasparetto, James W. Hardin, Shankar S. Srinivasan, Rosanna J. Ricafort, Yasir M. Nagarwala, Brian G.M. Durie · 2014 · Clinical Lymphoma Myeloma & Leukemia
  47. Increased microcirculation detected by dynamic contrast‐enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma
    Jens Hillengaß, Judith Ritsch, Maximilian Merz, Barbara Wagner, Christina Kunz, Thomas Hielscher, Hendrik Laue, Tobias Bäuerle, Christian M. Zechmann, Anthony Dick Ho et al. · 2016 · British Journal of Haematology
  48. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective
    Jo Caers, Carlos Fernández de Larrea, Xavier P Leleu, Roy Heusschen, Niklas Zojer, Olivier Decaux, Efstathios Kastritis, Monique C. Minnema, Artur J. Jurczyszyn, Yves P. Beguin et al. · 2016 · The Oncologist
  49. Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma
    Mohammed A. Aljama, M Hasib Sidiqi, Arjun Lakshman, Angela A. Dispenzieri, Dragan Jevremović, Morie Abraham Gertz, Martha Q. Lacy, Francis K. Buadi, David Dingli, Eli Muchtar et al. · 2018 · Blood Advances
  50. Imaging in myeloma with focus on advanced imaging techniques
    Tara D. Barwick, Laure Bretsztajn, Kathryn L. Wallitt, Dimitri Amiras, Andrea Rockall, Christina Messiou · 2019 · British Journal of Radiology
  51. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma
    Gaurav Goyal, S. Vincent Rajkumar, Martha Q. Lacy, Morie Abraham Gertz, Francis K. Buadi, Angela A. Dispenzieri, Yi L. Hwa, Amie L Fonder, Miriam Hobbs, Suzanne R. Hayman et al. · 2019 · Leukemia
  52. Risk factors of preseptal and orbital cellulitis.
    Tariq Farooq Babar, Mir Zaman, Mohammad Naeem Khan, Mohammad Daud Khan · 2009 · PubMed
  53. New horizons in our understanding of precursor multiple myeloma and early interception
    David M. Cordas dos Santos, Rosa Toenges, Luca Bertamini, Jean-Baptiste Alberge, Irene M. Ghobrial · 2024 · Nature reviews. Cancer
  54. Current Controversies in the Management of Myeloma Bone Disease
    Rebecca Wang Silbermann, G. David Roodman · 2016 · Journal of Cellular Physiology
  55. In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells
    Wilson I. Gonsalves, Jin Sung Jang, Erik Jessen, Taro Hitosugi, Laura A. Evans, Dragan Jevremović, Xuan-Mai Pettersson, Alexander Graham Bush, Jaimee Gransee, Emilie I. Anderson et al. · 2020 · Cancer & Metabolism
  56. Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients
    Maja Hinge, Kristian Andersen, Thomas Lund, Henrik Boel Jørgensen, Paw Christian Holdgaard, Tina Elisabeth Ormstrup, L. L. Ostergaard, Torben Plesner · 2016 · Haematologica
  57. Trends in survival of multiple myeloma: A thirty-year population-based study in a single institution
    Rafael Ríos, María‐José Sánchez, José Manuel Puerta, Juan Sáinz, D.Y.L. Chang, Teresa Rodríguez, Pilar López, José María De Pablos, Pilar Navarro, José Luís García de Veas Silva et al. · 2015 · Cancer Epidemiology
  58. The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma
    Jason B. Brayer, Rachid Baz · 2017 · Therapeutic Advances in Hematology
  59. Aberrant lncRNA Expression in Multiple Myeloma
    Hui Meng, Lei Han, Chun Hong, Jinya Ding, Qianchuan Huang · 2017 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  60. Cancer Immunoprevention: Current Status and Future Directions
    Mahsa Keshavarz‐Fathi, Nima Rezaei · 2021 · Archivum Immunologiae et Therapiae Experimentalis
  61. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance–Like Phenotype in Patients With Monoclonal Gammopathies
    Leire Burgos, Luis‐Esteban Tamariz‐Amador, Noemí Puig, María‐Teresa Cedena, Camila Guerrero, Tomáš Jelı́nek, Sadie Johnson, Paolo Milani, Lourdes Cordón, José Juan Pérez et al. · 2023 · Journal of Clinical Oncology
  62. A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcaemic action
    Michinori Hirata, Koichi Endo, K. Katsumata, Fumihiko Ichikawa, Noboru Kubodera, Masafumi Fukagawa · 2002 · Nephrology Dialysis Transplantation
  63. Effect of breast-feeding on the development of atopic dermatitis.
    Reza Ghaderi, Zahra Makhmalbaf · 2005 · PubMed · Retracted
  64. Mode of progression in smoldering multiple myeloma: a study of 406 patients
    Nadine H. Abdallah, Arjun Lakshman, Shaji Kunnathu Kumar, Joselle Cook, Moritz Binder, Prashant Kapoor, Angela A. Dispenzieri, Morie Abraham Gertz, Martha Q. Lacy, Suzanne R. Hayman et al. · 2024 · Blood Cancer Journal
  65. Vaccines for cancer prevention: exploring opportunities and navigating challenges
    Michele Graciotti, Lana Elias Kandalaft · 2024 · Nature Reviews Drug Discovery
  66. Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression
    Danielle C. Croucher, Laura M. Richards, Serges P. Tsofack, Daniel Dirck Waller, Zhihua Li, Ellen nong Wei, Xian Fang Huang, Marta Chesi, Peter Leif Bergsagel, Michaël Sébag et al. · 2021 · Nature Communications
  67. Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis
    Alissa Visram, S. Vincent Rajkumar, Prashant Kapoor, Angela A. Dispenzieri, Martha Q. Lacy, Morie Abraham Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis et al. · 2021 · Blood Cancer Journal
  68. Advancements in Nanomedicine for Multiple Myeloma
    Alexandre Detappe, Mark W. Bustoros, Tarek H. Mouhieddine, Paiman Peter Ghoroghchian · 2018 · Trends in Molecular Medicine
  69. How I approach smoldering multiple myeloma
    Iuliana Vaxman, Morie Abraham Gertz · 2022 · Blood
  70. Recent advances in multiple myeloma: a Korean perspective
    Junshik Hong, Jae Hoon Lee · 2016 · The Korean Journal of Internal Medicine
  71. Tuberculous mastitis.
    Uzma Jalali, Shahid Rasul, Asadullah Khan, Nasir Baig, Asmara Khan, Raheel Akhter · 2005 · PubMed
  72. Profile of elotuzumab and its potential in the treatment of multiple myeloma
    Frits van Rhee, Yi‐Chang Liu, Susann M. Szmania · 2014 · Blood and Lymphatic Cancer Targets and Therapy
  73. Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal Evolution
    Min Tang, Rui Zhao, Helgi J. Van de Velde, Jennifer G. Tross, Constantine S. Mitsiades, Suzanne Viselli, Rachel B. Neuwirth, Dixie-Lee W. Esseltine, Kenneth Carl Anderson, Irene M. Ghobrial et al. · 2016 · Clinical Cancer Research
  74. Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis
    Khaled Elsayad, Michael Oertel, Laila König, Sebastian Hüske, Emmanuelle Le Ray, M.A.M. Meheissen, Amr Abdelaziz Elsaid, Essam Elfaham, Jürgen Debus, Youlia M. Kirova et al. · 2020 · Cancers
  75. Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study
    Michael Alan Rosenzweig, Joycelynne Michelle Palmer, Ni‐Chun Tsai, Timothy Walter Synold, Xiwei Wu, Shu Tao, SAMANTHA NADIA HAMMOND, Ralf Buettner, Lupe Duarte, Myo Htut et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
  76. Persistent challenges with treating multiple myeloma early
    Aaron Michael Goodman, Myung Sun Kim, Vinay K. Prasad · 2020 · Blood
  77. Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events
    Ola Landgren · 2021 · Hematology
  78. Nontargeted and targeted metabolomics approaches reveal the key amino acid alterations involved in multiple myeloma
    Lingling Yue, Pengyun Zeng, Yanhong Li, Ye Chai, Chongyang Wu, Bingren Gao · 2022 · PeerJ
  79. Smoldering Multiple Myeloma
    S. Vincent Rajkumar, Peter Leif Bergsagel, Shaji Kunnathu Kumar · 2023 · Hematology/Oncology Clinics of North America
  80. Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method
    Elisabet Esteve Manasanch, Dalia Salem, Constance M. Yuan, Nishant Tageja, Manisha Bhutani, Mary Kwok, Dickran Gano Kazandjian, George Carter, Seth M. Steinberg, Diamond Zuchlinski et al. · 2014 · Leukemia & lymphoma/Leukemia and lymphoma
  81. Comparison of stem cell therapies for acute kidney injury.
    Carol J Barnes, Casey T Distaso, Kristin M Spitz, Valerie A Verdun, Aviad Haramati · 2010 · Europe PMC (PubMed Central)
  82. Whole-Body Imaging in Multiple Myeloma
    Christina Messiou, Martin Kaiser · 2018 · Magnetic Resonance Imaging Clinics of North America
  83. The Angiogenic Balance and Its Implications in Cancer and Cardiovascular Diseases: An Overview
    Cătălina Ionescu, Bogdan Oprea, Georgeta Ciobanu, Milena Georgescu, Ramona Bica, Garofiţa-Olivia Mateescu, Fidan Huseynova, Véronique Barragan‐Montero · 2022 · Medicina
  84. A historical perspective on milestones in multiple myeloma research
    Doménico Ribatti · 2017 · European Journal Of Haematology
  85. Progression with clinical features is associated with worse subsequent survival in multiple myeloma
    Rajshekhar Chakraborty, Hien D. Liu, Lisa A Rybicki, Jacqulyn Tomer, Jack Khouri, Robert M. Dean, Beth M Faiman, Matt E Kalaycio, Christy Joy Samaras, Navneet S. Majhail et al. · 2019 · American Journal of Hematology
  86. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
    Alejandro Medina, Cristina Jiménez, María Eugenia Sarasquete, Marcos González, Carmen Chillón, Ana Balanzategui, Isabel Prieto-Conde, María García‐Álvarez, Noemí Puig, Verónica González‐Calle et al. · 2020 · Blood Cancer Journal
  87. Requirements for operational cure in multiple myeloma
    Mohamad Mohty, Hervé Avet‐Loiseau, Jean‐Luc Harousseau · 2021 · Blood
  88. Recent advances in understanding multiple myeloma
    Binod Dhakal, Saulius Kazmiems Girnius, Parameswaran Hari · 2016 · F1000Research
  89. Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop
    Daryl Chen Lung Tan, Jae Hoon Lee, Wen-Ming Chen, Kazuyuki Shimizu, Jian Hou, Kenshi Suzuki, Weerasak Nawarawong, Shang‐Yi Huang, Chor Sang Chim, Kihyun Kım et al. · 2018 · Leukemia & lymphoma/Leukemia and lymphoma
  90. Hemorrhagic corpus luteum mimicking heterotopic pregnancy.
    Saba Sohail · 2005 · PubMed
  91. Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma
    Mihaela Rata, Matthew Blackledge, Erica D. Scurr, Jessica Mary Winfield, Dow‐Mu Koh, Alina Denisa Dragan, Antonio Candito, Alexander King, Winston J. Rennie, Suchi Gaba et al. · 2022 · Insights into Imaging
  92. Immediate Effects of Core-Stability Exercises and Clinical Massage on Dynamic-Balance Performance of Patients With Chronic Specific Low Back Pain
    Athanasios Trampas, Αναστασια Μπενεκα, Vivian Paraskevi Malliou, George Godolias, Periklis Vlachakis · 2014 · Journal of Sport Rehabilitation
  93. Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma
    Verónica González‐Calle, Julio Dávila, Fernando Escalante, Alfonso García de Coca, Carmen Aguilera, Rafael López, Abelardo Bárez, José María Alonso, Roberto Sosa Hernández, J M Hernández et al. · 2016 · Leukemia
  94. Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy
    Malin L. Hultcrantz, Tobias Svensson, Åsa Rangert Derolf, Sigurdur Yngvi Kristinsson, Ebba K. Lindqvist, Anders Ekbom, Fredrik N. Granath, Magnus Björkholm · 2014 · Cancer Medicine
  95. Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents
    Morie Abraham Gertz, Evangelos Terpos, Angela A. Dispenzieri, Shaji Kunnathu Kumar, Rupin Shah, Robert Zygmunt Orlowski, Efstathios Kastritis, Meletios Athanasios Dimopoulos, Jatin J. Shah · 2014 · Leukemia & lymphoma/Leukemia and lymphoma
  96. Knowledge, attitude and practices regarding tuberculosis and dots among interns in delhi, India.
    Sanjay Rajpal, Anshu Mittal, V K Dhingra, Rahul Malhotra, Rajni Gupta, Chetna Malhotra, D K Taneja · 2007 · PubMed
  97. Plasma Cell Tumors
    Noopur S Raje, Teru Hideshima, Andrew Jenho Yee, Kenneth Carl Anderson · 2017 · Wiley eBooks
  98. Genomics define malignant transformation in myeloma precursor conditions
    Maura, Francesco, Bergsagel, P. Leif, Ziccheddu, Bachisio, Kumar, Shaji, Maclachlan, Kylee, Derkach, Andriy, Garces, Juan-Jose, Firestone, Ross, Braggio, Esteban, Asmann, Yan et al. · 2026 · Journal of Clinical Oncology
  99. Multiple Myeloma Unpacked
    Francesca Gay, Edoardo Marchetti, Giuseppe Bertuglia · 2025 · Hematological Oncology
  100. Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies
    Alissa Visram, Joselle Cook, Rahma M. Warsame · 2021 · Hematology